Medroxyprogesterone: FDA adverse event reports
68,829 FDA FAERS reports mention Medroxyprogesterone. 56,348 reports have a serious outcome flag.
Reported reactions
- Meningioma: 11,308 reports
- Breast Cancer: 11,247 reports
- Breast Cancer Female: 10,256 reports
- Drug Ineffective: 2,249 reports
- Breast Cancer Metastatic: 1,981 reports
- Nausea: 1,869 reports
- Headache: 1,783 reports
- Pain: 1,651 reports
- Fatigue: 1,624 reports
- Depression: 1,537 reports
- Anxiety: 1,339 reports
- Dizziness: 1,339 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.